Physician
New York City Health and Hospitals Corporation
New York City Health and Hospitals Corporation was paid $16.91M by Medicaid between Jan 2018 and Oct 2024, across 379 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.
33Billing provider infoNEW YORK CITY HEALTH AND HOSPITALS CORPORATION
BRONX, NY 10467
BRONX, NY 10467
33aNPI1023024882assigned 08/01/2006
33bProvider typeInternal Medicine Physician
28Total paid$16.91M
24GClaims532,286
24DCodes billed379
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Internal Medicine Physician providers in New York
Rank by total paid#18 of 6,049
Median peer was paid$11K
This provider vs. median1,495×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KARLIN, MARJI controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,702 | $149K | |
| 2019 | 115,187 | $3.39M | |
| 2020 | 270,964 | $9.76M | |
| 2021 | 79,332 | $2.75M | |
| 2022 | 2,917 | $27K | |
| 2023 | 12,487 | $513K | |
| 2024incomplete | 8,697 | $328K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 14,172 | 13,218 | $2.23M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.4% | 23,918 | 21,150 | $1.24M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.7% | 7,347 | 6,862 | $1.13M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.3% | 13,214 | 11,761 | $1.06M |
| D0999 | Unspecified diagnostic procedure, by report | 4.4% | 4,656 | 4,481 | $744K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.0% | 6,852 | 6,330 | $678K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.9% | 3,753 | 3,572 | $652K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.6% | 3,070 | 1,560 | $435K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.1% | 8,012 | 7,302 | $348K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.7% | 16,957 | 14,924 | $293K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.6% | 6,399 | 5,929 | $265K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 6,408 | 6,185 | $244K |
367 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.3% | 6,160 | $224K |
| 99201 | 1.3% | 3,387 | $221K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.2% | 2,281 | $210K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 6,881 | $188K |
| 99442 | 1.1% | 5,062 | $184K | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 1,053 | $171K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,886 | $166K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,259 | $163K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,632 | $157K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,666 | $156K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 928 | $144K |
| 99285 | Emergency room visit (most serious) | <1% | 887 | $141K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,055 | $135K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 4,634 | $125K |
| 80053 | Comprehensive metabolic panel | <1% | 13,622 | $120K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 289 | $118K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,127 | $114K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 885 | $114K |
| 99443 | <1% | 1,857 | $114K | |
| 99404 | <1% | 64 | $113K | |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | <1% | 755 | $106K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 13,660 | $106K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12,243 | $94K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 453 | $91K |
| 86480 | <1% | 1,495 | $85K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,045 | $85K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,077 | $84K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,823 | $82K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 528 | $81K |
| 90461 | <1% | 8,007 | $80K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 2,194 | $78K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,059 | $77K |
| 86769 | <1% | 2,750 | $76K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 767 | $72K |
| 99441 | <1% | 3,656 | $72K | |
| 85027 | <1% | 18,199 | $65K | |
| 86703 | <1% | 4,360 | $64K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,702 | $64K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 344 | $63K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 693 | $60K |
| 76830 | Ultrasound, transvaginal | <1% | 764 | $58K |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,569 | $56K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 696 | $56K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,855 | $55K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,520 | $53K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 455 | $53K |
| 80061 | Lipid panel | <1% | 7,362 | $52K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 552 | $51K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 369 | $51K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,027 | $51K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,325 | $49K |
| 90651 | <1% | 1,563 | $49K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,862 | $49K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,701 | $48K |
| 83655 | <1% | 5,422 | $48K | |
| H0040 | Assertive community treatment program, per diem | <1% | 143 | $47K |
| 86850 | <1% | 3,130 | $47K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,510 | $46K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 529 | $46K |
| 90715 | <1% | 1,852 | $45K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 317 | $43K |
| 86901 | <1% | 3,150 | $43K | |
| D1120 | Dental cleaning, child | <1% | 2,804 | $42K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 304 | $41K |
| 88142 | <1% | 1,719 | $41K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 4,066 | $40K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,857 | $40K |
| 97802 | <1% | 2,060 | $40K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,477 | $39K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,129 | $37K |
| 90686 | <1% | 4,726 | $37K | |
| 86360 | <1% | 646 | $36K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 986 | $35K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,187 | $35K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 958 | $33K |
| 86780 | <1% | 3,127 | $32K | |
| 76801 | <1% | 278 | $32K | |
| 87535 | <1% | 803 | $32K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 512 | $29K |
| D1206 | Topical application of fluoride varnish | <1% | 3,918 | $28K |
| 86359 | <1% | 646 | $28K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,106 | $26K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 612 | $26K |
| D0120 | Dental checkup, returning patient | <1% | 2,227 | $25K |
| 86900 | <1% | 3,143 | $22K | |
| 76813 | <1% | 202 | $22K | |
| 84703 | <1% | 7,362 | $22K | |
| 86803 | <1% | 2,383 | $22K | |
| 99381 | <1% | 2,811 | $21K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,161 | $20K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 139 | $19K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,321 | $17K |
| 87340 | <1% | 2,147 | $16K | |
| 92015 | Determination of refractive state | <1% | 629 | $16K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 502 | $15K |
| 86880 | <1% | 2,014 | $15K | |
| 99205 | Prolong outpt/office vis | <1% | 73 | $14K |
| 90670 | <1% | 1,555 | $14K | |
| 76641 | <1% | 127 | $14K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 1,859 | $14K |
| 86762 | <1% | 1,192 | $14K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 789 | $14K |
| 84702 | <1% | 2,292 | $13K | |
| 97803 | <1% | 523 | $13K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 168 | $13K |
| 83020 | <1% | 869 | $12K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 572 | $12K |
| 58300 | <1% | 102 | $12K | |
| 86765 | <1% | 1,174 | $12K | |
| D0330 | Panoramic radiographic image | <1% | 891 | $11K |
| 84439 | <1% | 2,090 | $11K | |
| 81003 | <1% | 6,084 | $11K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 594 | $11K |
| 59841 | <1% | 17 | $11K | |
| 0001A | <1% | 540 | $11K | |
| 59025 | Fetal non-stress test | <1% | 143 | $10K |
| 86735 | <1% | 1,172 | $10K | |
| 99412 | <1% | 869 | $10K | |
| 0011A | <1% | 690 | $10K | |
| 86787 | <1% | 1,171 | $10K | |
| 90674 | <1% | 525 | $10K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 166 | $10K |
| D1351 | Sealant - per tooth | <1% | 1,045 | $10K |
| 0002A | <1% | 314 | $9K | |
| D0272 | Bitewings - two radiographic images | <1% | 1,747 | $9K |
| 97010 | <1% | 1,436 | $9K | |
| 58301 | <1% | 61 | $9K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 66 | $9K |
| 83001 | <1% | 440 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,284 | $9K |
| 81025 | <1% | 1,122 | $8K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 12 | $8K |
| 87081 | <1% | 2,379 | $8K | |
| 82728 | <1% | 933 | $8K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 142 | $8K |
| 76818 | <1% | 68 | $8K | |
| 99384 | <1% | 67 | $7K | |
| 90648 | <1% | 1,586 | $7K | |
| D9990 | <1% | 1,113 | $7K | |
| 84146 | <1% | 359 | $7K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 1,484 | $7K |
| 81001 | <1% | 6,417 | $7K | |
| 83880 | <1% | 408 | $7K | |
| 80076 | <1% | 1,147 | $7K | |
| 72100 | <1% | 275 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,008 | $7K |
| 90723 | <1% | 1,314 | $7K | |
| 84403 | <1% | 226 | $6K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 726 | $6K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 403 | $6K |
| 82951 | <1% | 562 | $6K | |
| 73630 | <1% | 255 | $6K | |
| 85060 | <1% | 412 | $6K | |
| 82105 | <1% | 452 | $6K | |
| 73564 | <1% | 187 | $6K | |
| 86706 | <1% | 1,155 | $6K | |
| 11720 | <1% | 63 | $6K | |
| 73030 | <1% | 282 | $5K | |
| 73130 | <1% | 224 | $5K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 930 | $5K |
| 97165 | <1% | 55 | $5K | |
| 82948 | <1% | 3,083 | $5K | |
| 96127 | <1% | 1,289 | $5K | |
| 11721 | <1% | 26 | $5K | |
| 94664 | <1% | 531 | $5K | |
| 82607 | <1% | 388 | $5K | |
| 86235 | <1% | 65 | $5K | |
| 90734 | <1% | 244 | $5K | |
| 99383 | <1% | 58 | $4K | |
| 76820 | <1% | 82 | $4K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 40 | $4K |
| D1110 | Prophylaxis - adult | <1% | 387 | $4K |
| 90681 | <1% | 842 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 416 | $4K |
| 73610 | <1% | 202 | $4K | |
| 85610 | <1% | 2,736 | $4K | |
| 90707 | <1% | 290 | $4K | |
| 92558 | <1% | 131 | $4K | |
| 90732 | <1% | 44 | $4K | |
| 83002 | <1% | 183 | $4K | |
| 97161 | <1% | 41 | $4K | |
| 83516 | <1% | 202 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,909 | $3K |
| 83550 | <1% | 703 | $3K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 313 | $3K |
| 80320 | <1% | 1,155 | $3K | |
| 71045 | Radiologic examination, chest; single view | <1% | 308 | $3K |
| 83525 | <1% | 333 | $3K | |
| 90633 | <1% | 704 | $3K | |
| 90474 | <1% | 601 | $3K | |
| 90716 | <1% | 259 | $3K | |
| 82677 | <1% | 156 | $3K | |
| 83540 | <1% | 849 | $3K | |
| 85007 | <1% | 1,305 | $3K | |
| 87186 | <1% | 866 | $3K | |
| 85730 | <1% | 2,564 | $3K | |
| D1354 | <1% | 799 | $3K | |
| 87536 | <1% | 26 | $3K | |
| 77080 | <1% | 60 | $3K | |
| 0012A | <1% | 130 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 24 | $3K |
| 84480 | <1% | 266 | $3K | |
| 97804 | <1% | 379 | $3K | |
| 92250 | <1% | 77 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 15 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,935 | $2K |
| 73560 | <1% | 79 | $2K | |
| 90746 | <1% | 40 | $2K | |
| 73140 | <1% | 111 | $2K | |
| 82947 | <1% | 527 | $2K | |
| 83883 | <1% | 111 | $2K | |
| 86140 | <1% | 616 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 252 | $2K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 346 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 430 | $2K |
| 84402 | <1% | 82 | $2K | |
| 90620 | <1% | 120 | $2K | |
| 76376 | <1% | 38 | $2K | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | <1% | 341 | $2K |
| 82784 | <1% | 107 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,672 | $2K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 88 | $2K |
| 84704 | <1% | 154 | $2K | |
| 84484 | <1% | 1,666 | $2K | |
| 82043 | <1% | 565 | $2K | |
| 74019 | <1% | 60 | $2K | |
| 83970 | <1% | 43 | $2K | |
| 88304 | <1% | 57 | $2K | |
| 86336 | <1% | 154 | $2K | |
| 86704 | <1% | 203 | $2K | |
| 85651 | <1% | 672 | $2K | |
| 92586 | <1% | 15 | $2K | |
| 92083 | <1% | 25 | $2K | |
| 82785 | <1% | 84 | $2K | |
| 83690 | <1% | 1,669 | $2K | |
| 73110 | <1% | 63 | $1K | |
| D0274 | Bitewings - four radiographic images | <1% | 258 | $1K |
| 76998 | <1% | 13 | $1K | |
| 99385 | <1% | 15 | $1K | |
| 82670 | <1% | 50 | $1K | |
| 82570 | <1% | 524 | $1K | |
| Q3014 | Telehealth originating site facility fee | <1% | 266 | $1K |
| 90700 | <1% | 195 | $1K | |
| 82550 | <1% | 799 | $1K | |
| 86592 | <1% | 442 | $1K | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 176 | $1K |
| 83735 | <1% | 734 | $1K | |
| 90710 | <1% | 271 | $1K | |
| 92579 | <1% | 12 | $964.23 | |
| 85045 | <1% | 335 | $955.27 | |
| J2704 | Injection, propofol, 10 mg | <1% | 550 | $948.27 |
| 86141 | <1% | 289 | $885.85 | |
| T2022 | Case management, per month | <1% | 22 | $843.15 |
| 59425 | <1% | 13 | $817.00 | |
| 82627 | <1% | 33 | $815.35 | |
| 87077 | <1% | 527 | $779.94 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 838 | $766.77 |
| 84156 | <1% | 330 | $732.80 | |
| 92567 | <1% | 27 | $727.59 | |
| 94760 | <1% | 613 | $720.92 | |
| 73120 | <1% | 27 | $701.67 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 817 | $686.70 |
| 84100 | <1% | 571 | $674.54 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 52 | $625.91 |
| 86255 | <1% | 27 | $590.15 | |
| 85379 | <1% | 304 | $559.88 | |
| 96161 | <1% | 400 | $538.18 | |
| 97124 | <1% | 19 | $528.91 | |
| 86580 | <1% | 87 | $507.82 | |
| 82805 | <1% | 37 | $502.17 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 111 | $501.34 |
| 83498 | <1% | 15 | $456.40 | |
| 88141 | <1% | 33 | $455.56 | |
| 86593 | <1% | 106 | $450.12 | |
| 84153 | <1% | 25 | $434.58 | |
| 73562 | <1% | 14 | $412.14 | |
| 87070 | <1% | 550 | $411.91 | |
| 82248 | <1% | 106 | $404.43 | |
| 80165 | <1% | 75 | $402.85 | |
| 87800 | <1% | 13 | $399.37 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 675 | $375.48 |
| 81002 | <1% | 84 | $350.60 | |
| 83605 | <1% | 271 | $350.45 | |
| 86376 | <1% | 25 | $347.64 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,489 | $340.85 |
| 73600 | <1% | 29 | $335.29 | |
| 86038 | <1% | 43 | $332.98 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 232 | $327.86 |
| 83615 | <1% | 137 | $326.80 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 901 | $303.27 |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 205 | $301.95 |
| 73502 | <1% | 14 | $299.06 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 334 | $296.48 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 588 | $290.35 |
| 90696 | <1% | 108 | $286.33 | |
| 99411 | <1% | 140 | $277.92 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,162 | $262.38 |
| 82397 | <1% | 46 | $260.11 | |
| 82952 | <1% | 84 | $252.32 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 366 | $241.45 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 518 | $235.18 |
| 90749 | <1% | 240 | $232.54 | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 36 | $210.19 |
| D0191 | <1% | 212 | $199.94 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 295 | $198.66 |
| 82465 | <1% | 53 | $193.06 | |
| D0240 | <1% | 79 | $191.82 | |
| 80178 | <1% | 60 | $177.92 | |
| 87420 | <1% | 72 | $167.16 | |
| 87045 | <1% | 36 | $149.69 | |
| 84550 | <1% | 53 | $147.66 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 56 | $140.89 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 503 | $131.92 |
| 82977 | <1% | 17 | $123.08 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 306 | $120.86 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 207 | $110.68 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 222 | $109.57 |
| 86705 | <1% | 12 | $105.73 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 251 | $100.92 |
| 87040 | <1% | 75 | $99.38 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 776 | $95.05 |
| 96376 | <1% | 51 | $85.52 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 155 | $78.94 |
| 84155 | <1% | 24 | $77.34 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 223 | $74.45 |
| 82272 | <1% | 14 | $59.20 | |
| D0270 | <1% | 12 | $45.50 | |
| 84436 | <1% | 68 | $44.63 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 28 | $44.40 |
| 94761 | <1% | 12 | $43.23 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 286 | $39.78 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,524 | $38.23 |
| 82803 | <1% | 27 | $30.59 | |
| 82150 | <1% | 13 | $25.76 | |
| 82010 | <1% | 16 | $21.73 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 69 | $19.67 |
| 99173 | <1% | 76 | $12.20 | |
| 84512 | <1% | 29 | $5.28 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 12 | $4.72 |
| J1815 | Injection, insulin, per 5 units | <1% | 14 | $2.86 |
| 3078F | <1% | 211 | $1.80 | |
| 99080 | 0% | 2,742 | $0.00 | |
| 99499 | 0% | 464 | $0.00 | |
| 99408 | 0% | 379 | $0.00 | |
| 90685 | 0% | 142 | $0.00 | |
| 3077F | 0% | 12 | $0.00 | |
| 1159F | 0% | 12 | $0.00 | |
| 1160F | 0% | 12 | $0.00 | |
| 2022F | 0% | 15 | $0.00 | |
| 87400 | 0% | 16 | $0.00 | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 0% | 14 | $0.00 |
| 92002 | 0% | 12 | $0.00 | |
| 3044F | 0% | 220 | $0.00 | |
| 4293F | 0% | 416 | $0.00 | |
| 92551 | 0% | 63 | $0.00 | |
| D0603 | 0% | 663 | $0.00 | |
| 1125F | 0% | 42 | $0.00 | |
| 80050 | General health panel | 0% | 461 | $0.00 |
| 1220F | 0% | 1,595 | $0.00 | |
| 3074F | 0% | 221 | $0.00 | |
| D0602 | 0% | 25 | $0.00 | |
| 99406 | 0% | 367 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 66 | $0.00 |
| 1170F | 0% | 42 | $0.00 | |
| 3079F | 0% | 26 | $0.00 | |
| 90647 | 0% | 19 | $0.00 | |
| 3075F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKARLIN, MARJI (CHIEF REVENUE OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.